Target intelligence / Profile preview

Cytoplasmic FMR1-interacting protein 2 (CYFIP2)

Target
CYFIP2
Molecular classification
Other (multifunctional adaptor protein), WAVE regulatory complex component, RNA-binding protein interactor
01

Overview

Cytoplasmic FMR1-interacting protein 2 (CYFIP2) is an evolutionarily conserved protein encoded by the CYFIP2 gene in humans. It is a core component of the WAVE regulatory complex (WRC), which controls actin cytoskeleton dynamics critical for neuronal development, dendritic spine morphology, and synaptic function. CYFIP2 also interacts directly with the fragile X mental retardation protein (FMRP) as well as related translation regulators, linking mRNA transport/local translation to cytoskeletal regulation. Mutations in CYFIP2, particularly de novo variants clustering within key protein domains, have been identified as the cause of severe neurodevelopmental disorders such as early infantile epileptic encephalopathy (EIEE65), characterized by profound intellectual disability, early-onset seizures, and muscular hypotonia. While highly homologous to CYFIP1, CYFIP2 has unique neuronal functions and protein interaction networks. Complete absence of CYFIP2 leads to early postnatal lethality in animal models, demonstrating its essential role in nervous system development. There are currently no drugs known to directly target CYFIP2.

Other names
KIAA1168PIR121p53-inducible protein 121DEE65EIEE65SRA-1cytoplasmic FMRP interacting protein 2
02

Biological functions

Actin cytoskeleton organizationRegulation of mRNA translationSynaptic functionRegulation of neuronal developmentDendritic spine morphogenesis
03

Disease associations

Neurodevelopmental disease (including early infantile epileptic encephalopathy/EIEE65)Intellectual disabilitySeizure disorder/epilepsyPotentially autism spectrum disorder (as a candidate gene)
04

Safety considerations

Loss-of-function or pathogenic variation results in severe neurodevelopmental disorders, including intellectual disability, seizures, and hypotoniaEssential for brain development and survival (complete knockout is lethal in animal models)

Beyond the preview

Go deeper on Cytoplasmic FMR1-interacting protein 2 (CYFIP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytoplasmic FMR1-interacting protein 2 (CYFIP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call